Clinical Trial Results:
A double-blind placebo-controlled study of the safety, tolerability and efficacy of 12 months’ treatment with ACI-91 in patients with mild to moderate Alzheimer’s Disease
Summary
|
|
EudraCT number |
2008-005260-14 |
Trial protocol |
DE AT |
Global completion date |
17 Jan 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
02 Jun 2019
|
First version publication date |
02 Jun 2019
|
Other versions |
|
Summary report(s) |
Tables Listings Figures efficacy Figures Safety Figures Biochemistry Figures PK |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.